About Michael McCaman
Form D filings for Orion Therapeutics from 2022 to 2024 list Michael McCaman as executive officer and director.
Michael McCaman first appears on SEC filings in 2022.
Experience
This experience comes from SEC filings. The years are when the filings name Michael McCaman in the role, so the role may have started earlier or lasted longer.
Key Colleagues at Startups
The people Michael McCaman works with at each company, as listed on that company's latest Form D.
Orion Therapeutics, Inc. · Form D, Sep 25, 2024
DM
Deidra Mountain
Director
RF
Richard Fisher
Executive officer and director